Abstract:Introduction Recent studies suggested that growth differentiation factor 15 (GDF-15) may indicate heart failure and a constellation of cardiovascular co-morbidities in diabetic patients. Whereas N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) is a cardiac-specific biomarker, GDF-15 is non-tissue-specific and may be a useful marker of global cardiovascular disease (CVD) burden, particularly in diabetes. In this systematic review and meta-analysis, we summarized the effects of elevated GDF-15 on the composite outcome of cardiovascular disease, events, and/or death in diabetic patients. Methods MEDLINE, EMBASE, CINAHL and Cochrane Library were queried for articles published from inception until February 2020. Longitudinal studies that reported data about the relationship between GDF-15 levels and CVD outcomes in diabetic patients were included. Pooled hazard ratios (HRs) for mortality were calculated and presented with 95% confidence intervals (CIs). Prespecified I2 threshold values of 25%, 50%, and 75% were used to indicate low, moderate, and high levels of heterogeneity, respectively. The risk of bias in the included studies was evaluated according to the criteria established by the Cochrane collaboration. Publication bias was assessed using funnel plot analysis. Results Seven studies with a total 15,805 diabetic patients were included (Fig. 1). The median follow-up ranged from 1.5 to 7.9 years. Pooled effect estimate suggested that elevated GDF-15 levels at baseline was associated with an increased risk for composite CVD-related outcome(s) (per standard deviation (SD) increase in log(GDF-15): HR 1.26, 95% CI 1.12-1.42, P = 0.0001, I2 for heterogeneity 85%, n = 15,651 patients) (Fig. 2a). When an unadjusted study was excluded, the pooled effect estimate remained statistically significant, with improvement in heterogeneity (per SD increase in log(GDF-15): HR 1.16, 95% CI 1.11-1.20, P <0.00001; I2 16%, n = 14,732 patients) (Fig. 2b). In four studies that reported an association between GDF-15 and all-cause mortality, the pooled analysis suggested that per SD increase in log(GDF-15) concentration, there was a significant increase in the risk for all-cause death (HR 1.76, 95% CI 1.23-2.53, P = 0.002); however, marked study heterogeneity (I2 92%, P <0.001) was observed (Fig. 2c). The pooled HR for all-cause death and GDF-15 remained significant even after excluding the unadjusted study. Conclusion Findings from this systematic review and meta-analysis suggest that elevated GDF-15 levels are associated with increased risk for incident cardiovascular endpoint(s) including acute cardiovascular events, heart failure and/or all-cause death in diabetic patients.

Raised Circulating Soluble Growth Differentiation Factor 15 is Negatively Associated with Testosterone Level in Hypogonadic Men with Type 2 Diabetes.

Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15

Correlations between growth differentiation factor 15 (GDF-15) serum levels and gene polymorphism with type 2 diabetes mellitus

Low Total Testosterone Levels in Men with Newly Diagnosed Early-Onset Type 2 Diabetes: A Cross-Sectional Study in China

Association of high circulating testosterone with increased glycaemic variability in type 2 diabetes: A cross-sectional study in China

Associations of GDF-15 and GDF-15/adiponectin Ratio with Odds of Type 2 Diabetes in the Chinese Population

Factors Defining the Association Between Vitamin D and Testosterone in Males With Type 2 Diabetes and Hypogonadism

Association Between Testosterone with Type 2 Diabetes in Adult Males, a Meta-Analysis and Trial Sequential Analysis

Association of Gonadal Hormones and Sex Hormone Binding Globulin with Risk of Diabetes: A Cohort Study in Middle‐aged and Elderly Chinese Males

GoGoGo : Improving Deep Neural Network Based Go Playing AI with Residual Networks

Associations of serum testosterone with different classes of glucose metabolism and the mediation effect of obesity on this relationship: The Henan rural cohort study.

The Association Among Serum Growth Differentiation Factor 15 Level and Suicidal Ideation is Dependent on Testosterone Deficiency in Depressive Patients

Correlation Between Gut Microbiota and Testosterone in Male Patients With Type 2 Diabetes Mellitus

Associations between Sex Hormones and Circulating Growth Differentiation Factor-15 in Male Patients with Major Depressive Disorder

Growth differentiation factor–15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis

Growth Differentiation Factor 15 As a Composite Diabetic Cardiovascular Disease Indicator Including Heart Failure: A Systematic Review and Meta-Analysis

Serum growth differentiation factor 15 is closely associated with metabolic abnormalities in Chinese pregnant women

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels

Elevated Serum Growth Differentiation Factor 15 Levels in Hyperthyroid Patients

GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes

Serum Vitamin D Affected Type 2 Diabetes though Altering Lipid Profile and Modified the Effects of Testosterone on Diabetes Status